{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T03:27:57Z","timestamp":1782790077530,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG-05119"],"award-info":[{"award-number":["AG-05119"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG-10836"],"award-info":[{"award-number":["AG-10836"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG-12141"],"award-info":[{"award-number":["AG-12141"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS-045615"],"award-info":[{"award-number":["NS-045615"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.neulet.2006.03.056","type":"journal-article","created":{"date-parts":[[2006,5,3]],"date-time":"2006-05-03T09:21:07Z","timestamp":1146648067000},"page":"137-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["In vitro and in vivo neuroprotection by \u03b3-glutamylcysteine ethyl ester against MPTP: Relevance to the role of glutathione in Parkinson's disease"],"prefix":"10.1016","volume":"402","author":[{"given":"Shankar J.","family":"Chinta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramanian","family":"Rajagopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Allan","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie K.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neulet.2006.03.056_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00024382-199408000-00001","article-title":"Thiol reducing agents modulate induced apoptosis in porcine endothelial cells","volume":"2","author":"Abello","year":"1994","journal-title":"Shock"},{"issue":"5","key":"10.1016\/j.neulet.2006.03.056_bib2","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1046\/j.1471-4159.1996.67052164.x","article-title":"Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons","volume":"67","author":"Andersen","year":"1996","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.neulet.2006.03.056_bib3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1460-9568.2005.03889.x","article-title":"A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease","volume":"21","author":"Bahat-Stroomza","year":"2005","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.neulet.2006.03.056_bib4","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/jnr.20394","article-title":"Gamma-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against Abeta(1\u201342)-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease","volume":"79","author":"Boyd-Kimball","year":"2005","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.neulet.2006.03.056_bib5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbrc.2004.09.033","article-title":"Glutathione precursors replenish decreased glutathione pool in cystinotic cell lines","volume":"324","author":"Chol","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.neulet.2006.03.056_bib6","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/jnr.10266","article-title":"Elevation of brain glutathione by gamma-glutamylcysteine ethyl ester protects against peroxynitrite-induced oxidative stress","volume":"68","author":"Drake","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neulet.2006.03.056_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson's disease","volume":"55","author":"Forno","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neulet.2006.03.056_bib8","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0028-3908(01)00019-3","article-title":"Oxidative stress induced neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier","volume":"40","author":"Gilgun-Sherki","year":"2001","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.neulet.2006.03.056_bib9","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1471-4159.2004.02929.x","article-title":"Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson's disease","volume":"92","author":"Hsu","year":"2005","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.neulet.2006.03.056_bib10","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1073\/pnas.88.5.1913","article-title":"Glutathione deficiency leads to mitochondrial damage in brain","volume":"88","author":"Jain","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"Suppl. 1","key":"10.1016\/j.neulet.2006.03.056_bib11","first-page":"24","article-title":"Oxidative mechanisms in nigral cell death in Parkinson's disease","volume":"13","author":"Jenner","year":"1998","journal-title":"Mov. Disord."},{"issue":"34","key":"10.1016\/j.neulet.2006.03.056_bib12","doi-asserted-by":"crossref","first-page":"26096","DOI":"10.1074\/jbc.M000120200","article-title":"Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease","volume":"275","author":"Jha","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2006.03.056_bib13","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","article-title":"Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo. A novel therapy for Parkinson's disease","volume":"37","author":"Kaur","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2006.03.056_bib14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1196\/annals.1297.059","article-title":"Glutathione metabolism during aging and in Alzheimer disease","volume":"1019","author":"Liu","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.neulet.2006.03.056_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/nbdi.2002.0507","article-title":"Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat","volume":"10","author":"McCormack","year":"2002","journal-title":"Neurobiol. Dis."},{"issue":"13","key":"10.1016\/j.neulet.2006.03.056_bib16","doi-asserted-by":"crossref","first-page":"9397","DOI":"10.1016\/S0021-9258(17)36891-6","article-title":"Glutathione-ascorbic acid antioxidant system in animals","volume":"269","author":"Meister","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2006.03.056_bib17","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev.bi.52.070183.003431","article-title":"Glutathione","author":"Meister","year":"1983","journal-title":"Annu. Rev. Biochem."},{"issue":"6\u20137","key":"10.1016\/j.neulet.2006.03.056_bib18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF01291884","article-title":"Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease","volume":"104","author":"Pearce","year":"1997","journal-title":"J. Neural. Trans."},{"issue":"3","key":"10.1016\/j.neulet.2006.03.056_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0304-3940(82)90390-1","article-title":"Parkinson's disease: a disorder due to nigral glutathione deficiency?","volume":"33","author":"Perry","year":"1982","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.neulet.2006.03.056_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0304-3940(86)90320-4","article-title":"Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients","volume":"67","author":"Perry","year":"1986","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2006.03.056_bib21","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/BF02631258","article-title":"Establishment and characterization of immortalized clonal cell lines from fetal rat mesencephalic tissue","volume":"30A","author":"Prasad","year":"1994","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"issue":"7","key":"10.1016\/j.neulet.2006.03.056_bib22","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0278-5846(96)00103-0","article-title":"Reduced intravenous glutathione in the treatment of early Parkinson's disease","volume":"20","author":"Sechi","year":"1996","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.neulet.2006.03.056_bib23","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0006-2952(97)00672-2","article-title":"Redox signaling and the emerging therapeutic potential of thiol antioxidants","volume":"55","author":"Sen","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neulet.2006.03.056_bib24","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0076-6879(96)64044-0","article-title":"Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines","volume":"264","author":"Trounce","year":"1996","journal-title":"Methods Enzymol."},{"issue":"4","key":"10.1016\/j.neulet.2006.03.056_bib25","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00001756-199603220-00018","article-title":"Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones","volume":"7","author":"Wullner","year":"1996","journal-title":"Neuroreport"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394006003399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394006003399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:04:43Z","timestamp":1759608283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394006003399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":25,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0304394006003399"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2006.03.056","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo neuroprotection by \u03b3-glutamylcysteine ethyl ester against MPTP: Relevance to the role of glutathione in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2006.03.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}